These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28086805)

  • 1. The safety of introducing a new generation TAVR device: one departments experience from introducing a second generation repositionable TAVR.
    Bjursten H; Nozohoor S; Johansson M; Zindovic I; Appel CF; Sjögren J; Dencker M; Olivecrona G; Harnek J; Koul S; Feldman T; Reardon MJ; Götberg M
    BMC Cardiovasc Disord; 2017 Jan; 17(1):25. PubMed ID: 28086805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial Single-Center Experience With the Fully Repositionable Transfemoral Lotus Aortic Valve System.
    Jarr KU; Leuschner F; Meder B; Katus HA; Bekeredjian R; Chorianopoulos E
    J Invasive Cardiol; 2017 Jan; 29(1):30-35. PubMed ID: 27845874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation devices for transfemoral transcatheter aortic valve replacement are superior compared with last generation devices with respect to VARC-2 outcome.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Cardiovasc Interv Ther; 2018 Jul; 33(3):247-255. PubMed ID: 28643214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the Lotus Valve System for treatment of patients with severe aortic valve stenosis and intermediate surgical risk: Results from the Nordic Lotus-TAVR registry.
    De Backer O; Götberg M; Ihlberg L; Packer E; Savontaus M; Nielsen NE; Jørgensen TH; Nykänen A; Baranowski J; Niemelä M; Eskola M; Bjursten H; Søndergaard L
    Int J Cardiol; 2016 Sep; 219():92-7. PubMed ID: 27288972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
    Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Clinical Outcomes of Transcatheter Aortic Valve Replacement in Left Ventricular Outflow Tract Calcification: New-Generation Device vs Early-Generation Device.
    Nomura T; Maeno Y; Yoon SH; Abramowitz Y; Israr S; Miyasaka M; Kazuno Y; Takahashi N; Kawamori H; Nakamura M; Jilaihawi H; Makkar RR
    J Invasive Cardiol; 2018 Nov; 30(11):421-427. PubMed ID: 30373952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfemoral aortic valve implantation with the repositionable Lotus valve compared with the balloon-expandable Edwards Sapien 3 valve.
    Wöhrle J; Gonska B; Rodewald C; Trepte U; Koch S; Scharnbeck D; Seeger J; Markovic S; Rottbauer W
    Int J Cardiol; 2015 Sep; 195():171-5. PubMed ID: 26043152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.
    Yoon SH; Lefèvre T; Ahn JM; Perlman GY; Dvir D; Latib A; Barbanti M; Deuschl F; De Backer O; Blanke P; Modine T; Pache G; Neumann FJ; Ruile P; Arai T; Ohno Y; Kaneko H; Tay E; Schofer N; Holy EW; Luk NHV; Yong G; Lu Q; Kong WKF; Hon J; Kao HL; Lee M; Yin WH; Park DW; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Kim HS; Butter C; Khalique OK; Schaefer U; Nietlispach F; Kodali SK; Leon MB; Ye J; Chevalier B; Leipsic J; Delgado V; Bax JJ; Tamburino C; Colombo A; Søndergaard L; Webb JG; Park SJ
    J Am Coll Cardiol; 2016 Sep; 68(11):1195-1205. PubMed ID: 27609682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of valve repositioning during transcatheter aortic valve replacement with the Lotus Valve System.
    Rashid HNZ; Gooley R; McCormick L; Zaman S; Ramkumar S; Jackson D; Amiruddin A; Nasis A; Cameron J; Meredith IT
    J Cardiol; 2017 Jul; 70(1):55-61. PubMed ID: 27890512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
    Rashid HN; McCormick LM; Talman AH; Ihdayhid AR; Nerlekar N; Amiruddin AS; Cameron J; Nasis A; Meredith IT; Gooley RP
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1365-1370. PubMed ID: 29210168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.
    Pilgrim T; Stortecky S; Nietlispach F; Heg D; Tueller D; Toggweiler S; Ferrari E; Noble S; Maisano F; Jeger R; Roffi M; Grünenfelder J; Huber C; Wenaweser P; Windecker S
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27856487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balloon-expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification.
    Abramowitz Y; Jilaihawi H; Chakravarty T; Kashif M; Matar G; Hariri B; Patel J; Nakamura M; Cheng W; Makkar RR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1173-9. PubMed ID: 26527374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transcatheter aortic valve implantation with the newest-generation Sapien 3 vs. Direct Flow Medical valve in a single center cohort.
    Schulz E; Jabs A; Tamm A; Herz P; Schulz A; Gori T; von Bardeleben S; Kasper-König W; Hink U; Vahl CF; Münzel T
    Int J Cardiol; 2017 Apr; 232():186-191. PubMed ID: 28089455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary?
    Tarantini G; Nai Fovino L; Tellaroli P; Purita P; Masiero G; Napodano M; Fraccaro C; Gerosa G; Iliceto S
    Int J Cardiol; 2017 Nov; 246():37-40. PubMed ID: 28867011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome.
    Murray MI; Geis N; Pleger ST; Kallenbach K; Katus HA; Bekeredjian R; Chorianopoulos E
    J Interv Cardiol; 2015 Feb; 28(1):109-16. PubMed ID: 25689554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.